Year 2020 / Volume 27 / Number 6

Avances en Dolor

New times are coming in spinal stimulation: implantation in a single phase

Rev. Soc. Esp. Dolor. 2020; 27(6): 336-337 / DOI: 10.20986/resed.2020.3877/2020

Concepción Pérez






Complete Article

New comment

Security code:
CAPTCHA code image
Speak the codeChange the code
 

Comments

No comments in this article

References

1. Eldabe S, Duarte RV, Gulve A, Thomson S, Baranidharan G, Houten R, et al. Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness (TRIAL-STIM)? A randomised controlled trial. Pain. 2020;161(12):2820-9. DOI: 10.1186/s13063-018-2993-9.
2. Simopoulos T, Sharma S, Aner M, Gill JS. A temporary vs. Permanent anchored percutaneous lead trial of spinal cord stimulation: a comparison of patient outcomes and adverse events. Neuromodulation. 2018;21(5):508-12. DOI: 10.1111/ner.12687.
3. Hoelzer BC, Bendel MA, Deer TR, Eldrige JS, Walega DR, Wang Z, et al. Spinal Cord Stimulator Implant Infection Rates and Risk Factors: A Multicenter Retrospective Study. Neuromodulation. 2017;20(6):558-62. DOI: 10.1111/ner.12609.
4. Falowski SM, Provenzano DA, Xia Y, Doth AH. Spinal Cord Stimulation Infection Rate and Risk Factors: Results From a United States Payer Database. Neuromodulation. 2019;22(2):179-89. DOI: 10.1111/ner.12843.
5. North R, Desai MJ, Vangeneugden J, Raftopoulos C, Van Havenbergh T, Deruytter M, et al. Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation. 2020;23(5):620-5. DOI: 10.1111/ner.13141.
6. Malige A, Sokunbi G. Spinal Cord Stimulators: A Comparison of the Trial Period Versus Permanent Outcomes. Spine (Phila Pa 1976). 2019;44(11):E687-E692. DOI: 10.1097/BRS.0000000000002921.
7. Deer TR, Sayed D, Pope JE, Chakravarthy KV, Petersen E, Moeschler SM, et al. Emergence From the COVID-19 Pandemic and the Care of Chronic Pain: Guidance for the Interventionalist. Anesth Analg. 2020;131(2):387-94. DOI: 10.1213/ANE.0000000000005000.
8. Mayoral Rojals V, Pérez Hernández C, Pérez Cajaraville J, Canós Verdecho A, Grupo de apoyo. Sociedad Española del Dolor (SED). Recomendaciones asistenciales para unidades de dolor ante la normalización progresiva de la actividad durante la pandemia por COVID-19. Rev Soc Esp Dolor. 2020;27(3):192-215. DOI: 10.20986/resed.2020.3821/2020.
9. Thomson S, Huygen F, Prangnell S, De Andrés J, Baranidharan G, Belaïd H, et al. Appropriate referral and selection of patients with chronic pain for spinal cord stimulation: European consensus recommendations and e-health tool. Eur J Pain. 2020;24(6):1169-81. DOI: 10.1002/ejp.1562.
10. Gallach-Solano E, Canós-Verdecho MA, Morales Suárez-Varela M. Protocolo psicológico para la evaluación de candidatos a implante de neuroestimulador. Rev Soc Esp Dolor. 2016;23(6):307-15. DOI: 10.20986/resed.2016.3467/2016.

Related articles

Citation tools

Pérez C. New times are coming in spinal stimulation: implantation in a single phase. Rev Soc Esp Dolor 2020; 27(6): 336-337 / DOI: 1020986/resed20203877/2020


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics

This article has received 178 visits.
This article has been downloaded 1 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Accepted: 22/12/2020

Online First: 22/12/2020

Published: 27/01/2021


Share

This article hasn't been rated yet.
Reader rating:
Rate this article:
© 2025 Revista de la Sociedad Española del Dolor
ISSN: 1134-8046   e-ISSN: 2254-6189

      Indexed in: